Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Blood Neoplasia|June 30, 2026
Ixazomib with chemotherapy for childhood relapsed acute lymphoblastic leukemia: a TACL consortium reportEric S Schafer, Holly L Pacenta, Yueh-Yun Chi, et al.
Nature Medicine|January 5, 2023
Pharmacotypes across the genomic landscape of pediatric acute lymphoblastic leukemia and impact on treatment responseShawn H R Lee, Wenjian Yang, Yoshihiro Gocho, et al.
Blood|May 20, 2015
Genome-wide analysis links NFATC2 with asparaginase hypersensitivityChristian A Fernandez, Colton Smith, Wenjian Yang, et al.
Pediatric Blood & Cancer|March 10, 2025
Venetoclax Combined With Chemotherapy in Pediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic LeukemiaAndrew E Place, Seth E Karol, Christopher J Forlenza, et al.
Journal of the National Cancer Institute|January 17, 2024
Additive effects of TPMT and NUDT15 on thiopurine toxicity in children with acute lymphoblastic leukemia across multiethnic populationsMaud Maillard, Rina Nishii, Wenjian Yang, et al.
Pediatric Blood & Cancer|March 9, 2019
No evidence that G6PD deficiency affects the efficacy or safety of daunorubicin in acute lymphoblastic leukemia induction therapyKatherine M Robinson, Wenjian Yang, Seth E Karol, et al.
Nature Communications|January 29, 2025
Molecular and pharmacological heterogeneity of ETV6::RUNX1 acute lymphoblastic leukemiaZhenhua Li, Huanbin Zhao, Wenjian Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2024
Impact of Age on Pharmacogenomics and Treatment Outcomes of B-Cell Acute Lymphoblastic LeukemiaSatoshi Yoshimura, Zhenhua Li, Yoshihiro Gocho, et al.
Pageof 9